What Are the Best Mega-Cap Stocks to Buy for 2024?
Investing.com | Dec 06, 2023 12:07
- Mega-cap stocks have been a favorite for long-term investors, providing stability, global reach, and consistent dividends.
- Using InvestingPro, we have curated a list of the top 36 mega-cap stocks.
- Our analysis has ultimately led us to two mega-cap stocks with significant growth potential that could beat the index in 2024.
- Missed out on Black Friday? Secure your up to 60% discount on InvestingPro subscriptions with our extended Cyber Monday sale.
Mega-cap stocks represent shares of companies listed on the US stock market with a market capitalization exceeding $200 billion, making them the largest publicly traded companies globally.
With the assistance of InvestingPro , let's arrange the mega-cap stocks in descending order. Here is the current list of the top 36 stocks ranked based on market cap:
These stocks also constitute the largest share in the S&P 500 index. Mega-cap stocks with a stable financial structure are especially favored by long-term investors, as they tend to offer more solid returns at low volatility. In addition, most of these stocks pay regular dividends and provide investors with a significant fixed income.
The stocks with the highest market capitalization, which are stable and relatively resistant to market fluctuations, are mostly companies operating in the technology sector.
Today, in our InvestingPro analysis, we evaluated the best mega-cap stocks to buy for 2024.
Among the stocks with a market capitalization of over $200 billion, we can see that two technology stocks stand out when we rank the shares of companies operating in the technology sector according to fair value and analyst targets.
Source: InvestingPro
The first of these stocks, Salesforce (NYSE:CRM), has the potential to rise close to 24% in a year according to InvestingPro.
Get The App
The other stock, Nvidia (NASDAQ:NVDA), has an upside forecast of less than 10% in the InvestingPro fair value analysis.
However, while the consensus forecast of analysts is an increase in the 35% band, it is thought that the stock is currently moving below its value.
Source: InvestingPro
In 2024, when we expand the screening of mega-cap stocks with upside potential to cover all sectors, we come across 6 stocks according to the fair value analysis.
Among these stocks, Shell (NYSE:SHEL) has the highest potential to increase in value within a year, with an increase of nearly 40%.
AstraZeneca (NASDAQ:AZN) is the only stock with an upside potential of more than 20% according to both InvestingPro's fair value analysis and analysts' consensus estimate.
Source: InvestingPro
On the other hand, when the portfolio of these stocks is compared to the one-year performance of the S&P 500, it can be seen that it provides an above-index return with a value increase of nearly 20%.
The average dividend yield of the shares was calculated as 1.8%.
***
You can easily determine whether a company is suitable for your risk profile by conducting a detailed fundamental analysis on InvestingPro according to your criteria. This way, you will get highly professional help in shaping your portfolio.
In addition, you can sign up for InvestingPro , one of the most comprehensive platforms in the market for portfolio management and fundamental analysis, much cheaper with the biggest discount of the year (up to 60%), by taking advantage of our extended Cyber Monday deal.
Disclaimer: The author does not own any of these shares. This content, which is prepared for purely educational purposes, cannot be considered as investment advice.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.